NLRC5: a newly discovered MHC class I transactivator (CITA)
- PMID: 22209772
- PMCID: PMC3323719
- DOI: 10.1016/j.micinf.2011.12.007
NLRC5: a newly discovered MHC class I transactivator (CITA)
Abstract
Major histocompatibility complex (MHC) class I and class II are crucial for the function of the human adaptive immune system. An NLR protein, CIITA (MHC class II transactivator), is a master regulator of MHC class II gene expression as well as of some of the genes involved in MHC class II antigen presentation. It has recently been discovered that another member of the NLR protein family, NLRC5, transcriptionally activates MHC class I genes, and thus acts as "CITA" (MHC class I transactivator), a counterpart to CIITA. In addition to MHC class I genes, NLRC5 can induce the expression of β2M, TAP1 and LMP2, essential components of MHC class I antigen presentation. These findings indicate that NLRC5 and CIITA are transcriptional regulators that orchestrate the concerted expression of critical components in the MHC class I and MHC class II pathways, respectively.
Copyright © 2011 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
Figures


References
-
- Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 1994;76:287–299. - PubMed
-
- Reith W, Mach B. The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 2001;19:331–373. - PubMed
-
- Ting JP, Trowsdale J. Genetic control of MHC class II expression. Cell. 2002;109(Suppl.):S21–33. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials